<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40939871</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>442</Volume><PubDate><Year>2025</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease.</ArticleTitle><Pagination><StartPage>133888</StartPage><MedlinePgn>133888</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2025.133888</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(25)00931-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with a history of coronary artery disease (CAD) presenting with ST-elevation myocardial infarction (STEMI) have high risk. We aimed to determine whether patients with CAD history presenting with STEMI had greater systemic inflammation and/or whether they benefitted similarly from IL-1 blockade.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We pooled data from three randomized clinical trials, including 139 patients with STEMI treated with anakinra or placebo. Patients were stratified by history of CAD defined as prior documented CAD, MI or coronary revascularization. The area under the curve (AUC) for C-reactive protein (CRP) was used to assess systemic inflammation. Event-free survival defined as the time from enrollment to the occurrence of a predefined adverse outcome, including new-onset heart failure, hospitalization for heart failure, or death, was compared using Cox regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 139 patients, 113 (81&#xa0;%) had no history of CAD, while 26 (19&#xa0;%) had a history of CAD. The CRP-AUC was significantly lower in the anakinra group compared placebo, independent of history of CAD: 85 [47-137] vs. 349 [154-580] mg&#xb7;day/L for anakinra and placebo, respectively, in patients with history of CAD, and 86 [43-179] vs. 213 [115-341] mg&#xb7;day/L in patients without CAD history; p for interaction&#xa0;=&#xa0;(0.27). No significant interactions were found between history of CAD and treatment allocation for the composite outcome for patients with and without history of CAD, respectively, p for interaction&#xa0;=&#xa0;(0.48).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">IL-1 blockade with anakinra in STEMI leads to similar reductions in systemic inflammation and improvement in HF-related outcomes inpatients both with and without history of CAD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Rocio I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States; Interventional Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golino</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States; Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogwood</LastName><ForeName>Austin C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchetta</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Buono</LastName><ForeName>Marco G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moroni</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbualungu</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agatiello</LastName><ForeName>Carla R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Interventional Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Tassell</LastName><ForeName>Benjamin W</ForeName><Initials>BW</Initials><AffiliationInfo><Affiliation>Department of Pharmacotherapy &amp; Outcomes Sciences, Virginia Commonwealth University, Richmond, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbate</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Robert M. Berne Cardiovascular Research Center and Department of Medicine, University of Virginia, Charlottesville, VA, United States. Electronic address: antonio.abbate@virginia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronary artery desease</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Interleukin-1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40939871</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2025.133888</ArticleId><ArticleId IdType="pii">S0167-5273(25)00931-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>